Biotech Investor Sees Covid-19 Drug Shaking Off Company’s Tarnished Past

(Bloomberg) -- Biotech investor Dale Chappell was looking to start Humanigen Inc. with a clean slate when his hedge fund assumed control in 2016, but things took longer than expected.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.